These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 9156935)

  • 1. [An effect of chromatographic fraction ultrafiltrate of plasma on aggregation of blood platelets in patients with chronic uremia].
    Popławski A; Myśliwiec M
    Pol Merkur Lekarski; 1996 Oct; 1(4):246-8. PubMed ID: 9156935
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Effect of chromatographic fractions of blood ultrafiltrates of patients with chronic uremia on the fibrinolytic activity]].
    Popławski A; Myśliwiec M; Soszka J
    Pol Tyg Lek; 1990 Oct 1-8; 45(40-41):810-3. PubMed ID: 2096374
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effect of ultrafiltrates in plasma from patients with chronic uremia on platelet aggregation].
    Myśliwiec M; Popławski A; Soszka J
    Pol Tyg Lek; 1991 Jan 21-28; 46(4-5):76-8. PubMed ID: 1845699
    [TBL] [Abstract][Full Text] [Related]  

  • 4. "In vitro" inhibition of platelet aggregation by uremic middle molecules.
    Gallice P; Fournier N; Crevat A; Saingra S; Frayssinet R; Murisasco A; Sicardi F
    Biomedicine; 1980; 33(6):185-8. PubMed ID: 7213919
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Elevated fibrinogen fragment levels in uremic plasma inhibit platelet function and expression of glycoprotein IIb-IIIa.
    Thekkedath UR; Chirananthavat T; Leypoldt JK; Cheung AK; Mohammad SF
    Am J Hematol; 2006 Dec; 81(12):915-26. PubMed ID: 16917914
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of transepithelial sodium transport in the frog skin by a low molecular weight fraction of uremic serum.
    Bourgoignie J; Klahr S; Bricker NS
    J Clin Invest; 1971 Feb; 50(2):303-11. PubMed ID: 5540168
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The binding of 125I-fibrinogen to blood platelets in patients with chronic uraemia.
    Komarnicki M; Zozulińska M; Zawilska K
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1987; 114(5):638-41. PubMed ID: 2448203
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Altered circadian rhythm of platelet aggregation in patients on longterm hemodialysis].
    Rydzewski A; Małyszko J; Borawski J; Pawlak D; Adamcewicz K; Buczko W; Myśliwiec M
    Przegl Lek; 1997; 54(3):167-70. PubMed ID: 9297192
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Modification of uremic thrombocytopathy by hemodialysis].
    Frick U; Frick G; Vitu J; Wiedenhöft I
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1983; 110(2):309-13. PubMed ID: 6194064
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Activation of blood platelets and the plasma coagulation system in patients with chronic uremia].
    Dmoszyńska-Giannopoulou A; Ksiazek A; Baran E; Pachucki Z
    Pol Tyg Lek; 1987 Jul; 42(30):915-7. PubMed ID: 3671183
    [No Abstract]   [Full Text] [Related]  

  • 11. Middle molecule accumulation in uremia: an "extra uremic factor".
    Oulès R; Emond C; Claret G; Branger B; Mion H; Mion C
    Artif Organs; 1981; 4 Suppl():177-83. PubMed ID: 7295089
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Examination of lymphokines in patients with hemodialysis (author's transl)].
    Löcsey L; Kálmán K; Hauck M; Kakuk G
    Allerg Immunol (Leipz); 1979; 25(3):211-7. PubMed ID: 162030
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effect of uremic plasma fractions of different molecular sizes on the filterability of red blood cells].
    Eggert W; Scigalla P; Noack C; Devaux S; Wolf S
    Z Urol Nephrol; 1981 May; 74(5):391-9. PubMed ID: 7269824
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Determination of endogenous middle molecules in normal and uremic body fluids.
    Fürst P; Zimmerman L; Bergström J
    Clin Nephrol; 1976 Apr; 3(2):178-88. PubMed ID: 1277595
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Isolation and partial characterization of platelet aggregation inhibitors in the blood of dialyzed patients.
    Mabuchi H; Nakahashi H
    Nephron; 1983; 35(2):112-5. PubMed ID: 6621755
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Peak 7c and creatinine weekly clearances in various dialytic procedures.
    Icardi A; Carozzi S; Trasforini D; Moriero E; Lamperi S
    Life Support Syst; 1983; 1 Suppl 1():162-5. PubMed ID: 6336401
    [No Abstract]   [Full Text] [Related]  

  • 17. Inhibition of phagocytosis by a middle molecular fraction from ultrafiltrate.
    Ringoir SM; van Landschoot N; de Smet R
    Clin Nephrol; 1980 Mar; 13(3):109-12. PubMed ID: 7379359
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chromatographic analysis of middle molecules in plasma ultrafiltrates of uraemic patients.
    Popławski A; Myśliwiec M
    Nephrol Dial Transplant; 1993; 8(2):188. PubMed ID: 8384345
    [No Abstract]   [Full Text] [Related]  

  • 19. [Study of the blood platelets in chronic dialyzed patients before and after hemodialysis. Comparison with a group of patients with grave chronic uremia treated with occasional dialysis].
    Praga C; Brancaccio D; Pogliani E; Della Grazia M
    Minerva Nefrol; 1968; 15(5):322-6. PubMed ID: 5743459
    [No Abstract]   [Full Text] [Related]  

  • 20. Removal of uremic toxins and regeneration of hemofiltrate by a selective dual hemofiltration artificial kidney (SEDUFARK) system.
    Jørstad S; Smeby LC; Widerøe TE; Berg KJ
    Clin Nephrol; 1980 Feb; 13(2):85-92. PubMed ID: 6988123
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.